Delivery Order SPE2D020D0005-SPE2D324F268B

Award Date 9/16/24
Potential Completion Date 9/19/24
Potential Value $2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $2,842.80 firm-fixed-price delivery order is for the supply of ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The award is part of a larger single-award Indefinite Delivery Contract (IDC) valued at over $7 million, which allows Chartwell RX to manufacture and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $3,354.27 delivery order is for the supply of 4566683111 - Ondansetron ODT 8 mg Tablet in 30-count packages. The contract is a Firm Fixed Price Indefinite Delivery Vehicle (IDV) that allows Chartwell RX to manufacture and distribute a broad range of medications, including oral antibiotics, antivirals,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $1,302.95 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, an antiemetic medication, to support government healthcare services. The contract has an ultimate completion date of June 6, 2025. Chartwell RX LLC is an experienced federal contractor, holding multiple Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical contractor based in Congers, New York. The $3,156.96 firm fixed price delivery order is for the supply of 30-count packages of the antiemetic medication ondansetron 8 mg orally disintegrating tablets (ODT) to support healthcare services for military personnel and other government beneficiaries. Chartwell RX is an experienced prime vendor for DLA and...
This federal contract award, identified as SPE2D020D0005|SPE2D324F251L, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, which is not set-aside, has a ceiling value of $4,738.00 and a completion date of September 12, 2024. The contract provides for the delivery of 4565729198 ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. Chartwell RX LLC...
This federal contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of 30-count packages of 8 mg ondansetron orally disintegrating tablets. Awarded by the Defense Logistics Agency (DLA) Troop Support Medical, this $3,946.20 firm fixed price delivery order does not have a set-aside designation. It is part of a larger $7 million-plus single-award indefinite delivery vehicle (IDV) contract held by Chartwell with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,842.80 firm fixed-price delivery order contract to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, which runs through August 2024, is for the provision of 4565467121 ondansetron orally disintegrating tablets (ODT) 4 mg. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) with Chartwell RX, valued at over $7 million and running through March 2030,...
This federal contract award to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, is a delivery order (SPE2D020D0005|SPE2D324F090W) valued at $4,143.51. The contract is for the supply of 4565064518 - Ondansetron ODT 8 mg Tablet 30s, a medication used to treat nausea and vomiting. The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense that provides medical supplies and services to military personnel and other...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract (SPE2D020D0005|SPE2D324F182T) to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The $2,842.80 Firm Fixed Price contract is for the delivery of 4565371887 - Ondansetron ODT 4 mg Tablets, 30-count. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) between Chartwell RX and DLA Troop Support Medical, valued at over $7 million and running...
  • SPE2D020D0005
    Indefinite Delivery Contract
  • SPE2D020D0005-SPE2D324F268B
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, with an award value of $1,973.10, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at over $7 million, which enables Chartwell RX to manufacture and distribute a broad range of medications to military treatment facilities globally.

The specific product being delivered under this order is 4,565,822 units of Ondansetron ODT 8 mg tablets. Ondansetron is an antiemetic medication used to prevent nausea and vomiting. This contract does not have a set-aside designation and is a firm-fixed-price contract with an ultimate completion date of September 19, 2024.

Chartwell RX LLC is also the prime contractor on a $139.7 million small business set-aside contract with the Department of Health and Human Services to provide doxycycline hyclate tablets and amoxicillin trihydrate capsules for the Strategic National Stockpile. The company supplies a variety of pharmaceutical products, including antibiotics, antivirals, and antifungals, to support the healthcare needs of military personnel, veterans, and other government beneficiaries.

Generated 12/16/24, 2:41 PM